Telemetry Investments’s Adaptimmune Therapeutics ADAP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-20,710
Closed -$170K 85
2017
Q3
$170K Buy
+20,710
New +$170K 0.06% 95